BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9559493)

  • 1. Molteno implant with mitomycin C: intermediate-term results.
    Perkins TW; Gangnon R; Ladd W; Kaufman PL; Libby CM
    J Glaucoma; 1998 Apr; 7(2):86-92. PubMed ID: 9559493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.
    Cantor L; Burgoyne J; Sanders S; Bhavnani V; Hoop J; Brizendine E
    J Glaucoma; 1998 Aug; 7(4):240-6. PubMed ID: 9713781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
    Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
    Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
    Anand N; Khan A
    J Glaucoma; 2009 Sep; 18(7):513-20. PubMed ID: 19223788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ahmed valve implantation with adjunctive mitomycin C and 5-fluorouracil: long-term outcomes.
    Alvarado JA; Hollander DA; Juster RP; Lee LC
    Am J Ophthalmol; 2008 Aug; 146(2):276-284. PubMed ID: 18538300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C as adjunctive therapy with glaucoma implant surgery.
    Susanna R; Nicolela MT; Takahashi WY
    Ophthalmic Surg; 1994 Jul; 25(7):458-62. PubMed ID: 7970517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molteno implant and refractory glaucoma. Evaluation of postoperative IOP control and complications with a modified surgical procedure].
    Hamard P; Loison-Dayma K; Kopel J; Hamard H; Baudouin C
    J Fr Ophtalmol; 2003 Jan; 26(1):15-23. PubMed ID: 12610405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
    Costa VP; Azuara-Blanco A; Netland PA; Lesk MR; Arcieri ES
    Ophthalmology; 2004 Jun; 111(6):1071-6. PubMed ID: 15177955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adjunctive mitomycin C in Molteno implant surgery.
    Lee D; Shin DH; Birt CM; Kim C; Kupin TH; Olivier MM; Khatana AK; Reed SY
    Ophthalmology; 1997 Dec; 104(12):2126-35. PubMed ID: 9400775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous use of mitomycin-C with Baerveldt implantation.
    Azuara-Blanco A; Moster MR; Wilson RP; Schmidt CM
    Ophthalmic Surg Lasers; 1997 Dec; 28(12):992-7. PubMed ID: 9427986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
    Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical revision of failed filtration surgery with mitomycin C augmentation.
    Anand N; Arora S
    J Glaucoma; 2007 Aug; 16(5):456-61. PubMed ID: 17700288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trabeculectomy with mitomycin C: intermediate-term results.
    Perkins TW; Gangnon R; Ladd W; Kaufman PL; Heatley GA
    J Glaucoma; 1998 Aug; 7(4):230-6. PubMed ID: 9713779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up.
    Sisto D; Vetrugno M; Trabucco T; Cantatore F; Ruggeri G; Sborgia C
    Acta Ophthalmol Scand; 2007 May; 85(3):267-71. PubMed ID: 17488455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate-term results of Baerveldt tube shunt surgery with mitomycin C use.
    Irak I; Moster MR; Fontanarosa J
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):189-96. PubMed ID: 15185786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C.
    Mietz H; Krieglstein GK
    Ophthalmic Surg Lasers; 1998 Aug; 29(8):628-34. PubMed ID: 9715486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Otago glaucoma surgery outcome study: comparative results for the 175-mm2 Molteno3 and double-plate molteno implants.
    Thompson AM; Molteno AC; Bevin TH; Herbison P
    JAMA Ophthalmol; 2013 Feb; 131(2):155-9. PubMed ID: 23411879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otago Glaucoma Surgery Outcome Study: follow-up of young patients who underwent Molteno implant surgery.
    Ah-Chan JJ; Molteno AC; Bevin TH; Herbison P
    Ophthalmology; 2005 Dec; 112(12):2137-42. PubMed ID: 16325709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin C eliminates the short-term intraocular pressure rise found following Molteno tube implantation.
    Ellingham RB; Morgan WH; Westlake W; House PH
    Clin Exp Ophthalmol; 2003 Jun; 31(3):191-8. PubMed ID: 12786768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive mitomycin C in Molteno implant surgery.
    Perkins TW; Cardakli UF; Eisele JR; Kaufman PL; Heatley GA
    Ophthalmology; 1995 Jan; 102(1):91-7. PubMed ID: 7831048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.